Deborah O'Neil

Biotechnology entrepreneur. Founder and CEO of NovaBiotics. Immunologist designing and developing much needed novel antimicrobial strategies for over 20 years.

[Deborah O'Neil @debsoneil]

Not only did the ‘driver’ ensure a 2 min silence either side of 1100, but I’m sure he dipped a wing at 1100 (not checking in case that was just a headwind coincidence…) Well done #Loganair

[Royal Society of Edinburgh @RoyalSocEd]

That's one week down of Curious 2023 - but there's still loads to come...

We've had a fantastic first week delving under the surface - from forensic science to primate research and everything in between!

Don't miss out on our exciting programme & visit https://t.co/dk5U8dMWPd

[Deborah O'Neil @debsoneil]

Looking forward very much to this event at the @RoyalSocEd. Please come along & join us! #WomenInSTEM

[Royal Society of Edinburgh @RoyalSocEd]

Leaders, pioneers, icons ✨👑

Join us for this event as we bring four of these world-leading scientists from the exhibition to the stage to share their inspirations and journeys through their STEM careers.

https://t.co/iim3XWdv9Y

[John Lewis & Partners @JohnLewisRetail]

It’s the things we do that mean the most. 🛹
#TheBeginner

[Deborah O'Neil @debsoneil]

@NovaBiotics @Jack_R_F_Bolton @durham_uni @bbscrc @Ukri Thanks Jack & @dougfp78. Great work & best of luck as you complete your PhD Jack.

[Deborah O'Neil @debsoneil]

@GillyMurphus I know!!! DH’s lastest ever one ☹️

[NovaBiotics Ltd @NovaBiotics]

Community Acquired Pneumonia (CAP) is an unmet global health & socioeconomic issue. Prevalence is increasing and a challenging winter CAP season driven by COVID, influenza & bacterial infections looms. Read more about NM002, our immunomodulator-antimicrobial candidate therapy 👇

[Larry the Cat @Number10cat]

“I can no longer, in good conscience, live with this Prime Minister. Either he goes, or I do”

[The Mould that Changed the World Musical 🎵 @ThatMould]

Are you a singing scientist or healthcare professional?
We need your help!! We’re recruiting our chorus for @edfringe. Auditions 14th & 21st of May in Edinburgh. Apply now at https://t.co/oGdgfw9xwK

[NovaBiotics Ltd @NovaBiotics]

Community Acquired Pneumonia (CAP) remains a significant cause of morbidity & mortality. At #eccmid @dougfp78 will present new data on NM002, our immunomodulatory-antimicrobial candidate in phase 3 clinical development for CAP.
Posters L0185, April 24th & L0476, April 25th

[BEAM Alliance @AllianceBEAM]

The #EU Pharma Legislation revision is on the horizon. What solutions do #SMEs need from our policymakers to unlock the innovation potential to tackle #AMR? Check out this video and don’t hesitate to spread the voice of SMEs too: like, share, and comment! https://t.co/h4SSOHkcWB

[Opportunity North East (ONE) @Opportunity_NE1]

Showcase session at #LifeSciencesSummit explores work of innovative #biotech and #healthtech businesses at different stages of growth @dyneval @EnteroBiotix @NovaBiotics @debsoneil Dr Rabinder Buttar @thetimesscot @SundayTimesScot #ONELifeSciences #BioHub @aberdeenuni

[NovaBiotics Ltd @NovaBiotics]

Today is the 5th #WorldAspergillosisDay, raising awareness of the diseases & complications of existing conditions #Aspergillus causes. Our novel antifungal peptide NP339 is being developed for invasive & respiratory Aspergillus infections.
#thinkfungus #drugdiscovery #immunology

[Deborah O'Neil @debsoneil]

A great opportunity 👇👇

[Opportunity North East (ONE) @Opportunity_NE1]

📣 Apply now for the #ONELifeSciences Boot Camp & Accelerator 👇
🌟 Test & develop your #lifesciences business concept
🌟 Create a compelling commercial proposition
🌟 Access up to £10k grant funding for your next steps
https://t.co/ljrf1M7oJY
#startup #Aberdeen #NEERSF

[Deborah O'Neil @debsoneil]

NovaBiotics Ltd #NACFC2021 poster presentation with @dougfp78 'on' very soon...👇👇

[NovaBiotics Ltd @NovaBiotics]

Don't miss @dougfp78 presenting new data in Poster #431 on 'Anti-virulence activities of cysteamine and protection from Pseudomonas toxicity in a Galleria mellonella model'

NACFC today at 1.10pm EST or 5.10pm GMT

#NACFC21 #CysticFibrosis #Antimicrobials #drugdiscovery2021

[Opportunity North East (ONE) @Opportunity_NE1]

Aberdeen biotech pioneer @NovaBiotics @debsoneil to share drug development progress at @eurconfmedmycol #TIMM2021 conference at @PandJLive in #Aberdeen, reports @pressjournal #lifesciences #biotech @aberdeenuni @SBF_ABDN @AFGTweets @Invest_Aberdeen @LifeSciScot

[BEAM Alliance @AllianceBEAM]

We urge #HERA to effectively support R&D in antimicrobial resistance. Read our full statement on the recent proposal here: https://t.co/T6DqaV7THX

[Deborah O'Neil @debsoneil]

Our latest publication, drilling further down into the mechanism of NM001 against Pseudomonas aeruginosa, still a major, poorly served driver of pathology in #cysticfibrosis. NM001 has potential in #CF, but also in other respiratory disease & against other bacterial pathogens👇👇

[NovaBiotics Ltd @NovaBiotics]

Very pleased to share further mechanistic insights highlighting the potential of our NM001 therapy candidate for #cysticfibrosis. Our latest publication is now out in a special Pseudomonas aeruginosa focused edition of @FrontiersIn https://t.co/Ifwy6FsCCv

[Deborah O'Neil @debsoneil]

Congratulations to all of this years' unstoppable #EOYUK finalists 👏✨

[Deborah O'Neil @debsoneil]

@EOY_UK @NovaBiotics An absolute pleasure to be back on the UK panel & looking forward very much to spending time with this years’ amazing finalists & my esteemed judging teammates.